SourceWatch needs your financial support to survive and thrive. If you've found this information on the people, organizations, and issues shaping the public agenda helpful, please make a tax-deductible donation now.

Johnson & Johnson

From SourceWatch

Jump to: navigation, search


This article is part of the Global corporations portal on SourceWatch.

Johnson & Johnson is a New Jersey based diversified, global pharmaceutical, health care product and consumer product company. It manufactures a variety of prescription medications and health care products as well as over-the-counter drugs, personal care products and food additives.

J&J operates 250 companies in 60 countries. It manufactures drugs for conditions which include neurological, blood and autoimmune diseases as well as pain medications. Top sellers include Risperdal for schizophrenia and Remicade for psoriasis. The company's medical devices and diagnostics division manufactures surgical equipment, monitoring devices, orthopedic products and contact lenses, among its products. Its consumer division includes over-the-counter drugs and products for babies, skin and oral care as well as first aid and women's health. In the fiscal year ending in December of 2008, the company reported global sales of approximately 63.75 billion dollars and had 118,700 employees world wide.[1]

Contents

Animal testing

Johnson & Johnson does animal testing.

Animals by species, numbers & locations (United States)

  • Johnson & Johnson, Skillman, New Jersey [2]

Facility information, progress reports & USDA-APHIS reports

For copies of this facility's U.S. Department of Agriculture-Animal Plant Health Inspection (APHIS) reports, other information and links, see also Stop Animal Experimentation NOW!: Facility Reports and Information. This Web site lists each of the 50 states; each state's name links to biomedical research facilities in that state, and to PDF copies of government documents where the facilities must report their animal usage.

Contract testing

Huntingdon Life Sciences (HLS) is the 3rd largest contract research organization (CRO) in the world and the largest animal testing facility in all of Europe. Firms hire HLS to conduct animal toxicity tests for agrochemicals, petrochemicals, household products, pharmaceutical drugs and toxins. HLS has a long history of gross animal welfare violations. See also Huntingdon Life Sciences.

Animal welfare & cruelty

Splenda: Sadistically Sweet

Splenda is the brand name for Sucralose, an artificial sweetner manufactured by by McNeil Speciality Products, a subsidiary of Johnson & Johnson. In 2000, a series of reports were published by Permagon press on the details of animal testing for Sucralose at HLS. These were particularly nasty experiments carried out on dogs, monkeys, rabbits, rats and mice. A total of 12,800 animals died at HLS during for this study. One of the objectives was to observe effects of massive doses of sucralose on animal's nervous systems. In spite of wide spread evidence of health dangers and concerns, Sucralose is widely available for consumption. See also pdf copies of animal testing reports for various species conducted at HLS laboratories. [4]

Sucralose is 600 times sweeter than sugar and is the first no-calorie based sweetener ever developed. It was predicted to be a highly profitable money maker for British sugar giant Tate & Lyle, who commissioned the research. Thousands of animals, including beagles, monkeys, rabbits and rodents were poisoned and killed in various ways for the 20 year study on Sucralose; known in the United States as Splenda. In the most shocking tests, 32 beagles were locked in metal cages for 52 weeks at the McNeil Speciality Products laboratories in New Jersey. They were given Sucralose mixed in with their normal feed while blood and urine samples were collected. At the end of the study, they were anaesthetised and bled to death by having their throats slit open. The dogs were then dissected to examine their organs for toxicity levels, more easily done as they were drained of blood. According to a report published in Food and Chemical Toxicology:

"Dogs were killed after 52 weeks of treatment by exsanguination (draining of blood) while under anaesthesia and examined." [5] See also Splenda: Sadistically Sweet.

Splenda health controversy

Splenda is derived from a chlorocarbon chemical which contains three atoms of chlorine per molecule (named sucralose by its manufacturer) and which is 600 times sweeter than a natural molecule of sugar. The use of "ose" implies that this substance is "natural" (as in sucrose) the name for table sugar. Johnson & Johnson has patented several chemical processes for manufacturing sucralose. The patent literature illustrates that sucralose can be chemically manufactured without natural sugar with an end product of an entirely new chlorocarbon chemical (sucralose). [6]

Centocor documercial

In February 2007, O'Dwyer's PR Daily reported that Johnson & Johnson's biopharmaceutical unit, Centocor had "developed a documentary film to serve as the centerpiece of a national campaign and an alternative to the 30-second spot." The film, called "Innerstate," follows "three patients living with chronic diseases like Crohn's disease, Rheumatoid arthritis, and psoriasis -- ailments for which Centocor markets treatments. Centocor's drugs aren't mentioned in the movie, however." [7]

Ad boycott against Air America Radio

Johnson & Johnson refused to advertise on the progressive Air America Radio. In October 2006, around 90 companies, including Johnson & Johnson, told ABC Radio Networks that they did not want their ads to play on radio stations that carried Air America Radio. [8], [9], [10]

Political contributions

Johnson & Johnson's political action committee (PAC) gave $542,000 to federal candidates in the 05/06 election cycle - 39% to Democrats and 61% to Republicans. [11]

Lobbying

The company spent $5,600,000 on lobbying in 2006. Of this total, $2,150,000 went to outside lobbying firms. Some of the firms were Ernst & Young, Hobbs Group, and Akin, Gump, Strauss, Hauer & Feld. [12]

Personnel

Key executives & pay

         Options
exercised
William Weldon, Chairman & CEO (age 60)    $10.76 million    $2.86 million
Dominic Caruso - VP Finance & CFO (age 51)    2.34 million    0
Russell C. Deyo - CCO (age 59)    2.99 million    736.00 K
Colleen A. Goggins - Chairman, Consumer & Personal Care (age 54)    3.39 million    872.00 K

[14]

Executive compensation

According to Fierce Pharma, J&J CEO, Bill Weldon was the third top wage earner in 2007 among pharmaceutical CEOs.

  • Total Compensation: $25.1M
  • 2007 Revenue: $61.1B
  • 2006 Revenue: $53.3B
  • Change: 14.6%
"Between base salary of $1.73 million, incentive pay of $9.19 million, plus stock awards and options and various miscellaneous perks, Johnson & Johnson's Bill Wledon raked in $25.1 million in compensation--almost $5 million more than in 2006. Other job perks added up to $179,231, including personal aircraft use ($118,653), and a car and driver and other personal transportation expenses ($29,753). Executive dining room meals, home security system monitoring fees, and financial planning totaled an additional $5,000."[15]

Selected board members

Contact

One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Phone: 732-524-0400

Fax: 732-214-0332

Web address: http://www.jnj.com

Articles & sources

SourceWatch articles

References

  1. Company Description: Johnson & Johnson, Hoovers, accessed December 2009
  2. Research Facilities: Johnson & Johnson Consumer Products, Skillman, New Jersey, Humane Society of the United States, accessed May 2009
  3. Research Facilities: Centocor, Malvern, Pennsylvania, accessed May 2009
  4. What Do They Test? Splenda: Coffee Sweetener, SHAC.net, accessed December 2009
  5. Mike Hamilton Sweetener Slaughter: 12,800 animals die for no-calorie pills, Daily Mirror, August 2001
  6. Do You Know What Your Children are Eating?, Truthaboutsplenda.com, accessed February 2009
  7. O'Dwyer's PR Daily Centocor Innerstate, February 2007
  8. Marc Fisher, "Air America, in the Throes of Victory?", The Washington Post, December 10, 2006.
  9. "Air America on Ad Blacklist?", FAIR, October 31, 2006.
  10. "Air America Blackout", FAIR.org/ABC memo, October 25, 2006.
  11. 2006 PAC Summary Data, Open Secrets, accessed October 2007.
  12. Johnson & Johnson lobbying expenses, Open Secrets, accessed October 2007.
  13. Company Description: Johnson & Johnson, Hoovers, accessed December 2009
  14. Johnson & Johnson Key Executives, Yahoo Finance, accessed December 2009
  15. J&J's Bill Weldon - CEO Pay, Fierce Pharma, Top 17 Paychecks in Big Pharma, May 2008
  16. Board of Directors, Johnson & Johnson, accessed October 2007.

External articles

External resources

Personal tools

Be a SourceWatcher!

Enter your e-mail address to get the Center for Media and Democracy's free weekly e-newsletter.